Resection and reconstruction of the left atrium with cardiopulmonary bypass for T4 non–small cell lung cancer
In the contemporary era of targeted and immunotherapy, surgical intervention may offer a viable alternative for patients with T4 NSCLC involving the left atrium who have exhibited resistance to neoadjuvant therapeutic regimens.
Authors
- Yangkai Li (ORCID: https://orcid.org/0000-0001-5342-5078)
- Kun Huang (ORCID: https://orcid.org/0000-0003-1641-1472)
- Xiangning Fu (ORCID: https://orcid.org/0000-0003-4670-1438)
- Lin Zhou (ORCID: https://orcid.org/0000-0001-6908-0764)
- Yu‐Chen Chen (ORCID: https://orcid.org/0000-0001-8434-7084)
- Zhipeng Hao
- Ni Zhang (ORCID: https://orcid.org/0000-0002-4563-6307)
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- JTCVS Techniques
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.xjtc.2025.01.029
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52